Literature DB >> 5009390

Human phosphoglycerate kinase and inactivation of the X chromosome.

B F Deys, K H Grzeschick, A Grzeschick, E R Jaffé, M Siniscalco.   

Abstract

The fibroblasts derived from the skin of a woman heterozygous for an X-linked deficiency of phosphoglycerate kinase represented a mosaic. Two of 22 clones with normal glucose-6-phosphate dehydrogenase activity and hypoxanthine(guanine) phosphoribosyltransferase activity had no phosphoglycerate kinase activity detected by electrophoresis. Because the loci for glucose-6-phosphate dehydrogeniase and hypoxanthine(guanine)phosphoribosyltransferase are already known to undergo inactivation and to be on the short arm of the X chromosome and the locus for phosphoglycerate kinase is on the long arm, these observations support the conclusion that the entire human X chromosome can be involved in X inactivation.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5009390     DOI: 10.1126/science.175.4025.1002

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  Hair root versus red cell individual phenotype in Sardinian heterozygotes for G6PD deficiency (Mediterranean type).

Authors:  G Romeo; A Rinaldi; F Urbano; G Filippi
Journal:  Am J Hum Genet       Date:  1976-09       Impact factor: 11.025

2.  X-chromosome inactivation in human liver: confirmation of X-linkage of ornithine transcarbamylase.

Authors:  F C Ricciuti; T D Gelehrter; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1976-07       Impact factor: 11.025

3.  Mosaicism for sulfoiduronate sulfatase deficiency in carriers of Hunter's syndrome.

Authors:  M R Capobianchi; G Romeo
Journal:  Experientia       Date:  1976-04-15

4.  Large-scale population study of human cell lines indicates that dosage compensation is virtually complete.

Authors:  Colette M Johnston; Frances L Lovell; Daniel A Leongamornlert; Barbara E Stranger; Emmanouil T Dermitzakis; Mark T Ross
Journal:  PLoS Genet       Date:  2007-12-13       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.